ING Group’s Radius Health, Inc. RDUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-221,753
Closed -$6.54M 886
2018
Q2
$6.54M Buy
+221,753
New +$7.01M 0.12% 103
2018
Q1
Sell
-7,247
Closed -$230K 854
2017
Q4
$230K Sell
7,247
-50,750
-88% -$1.59M ﹤0.01% 693
2017
Q3
$2.24M Buy
+57,997
New +$2.28M 0.04% 215
2017
Q2
Sell
-18,738
Closed -$724K 931
2017
Q1
$724K Buy
+18,738
New +$786K 0.01% 380
2016
Q4
Sell
-11,829
Closed -$653K 622
2016
Q3
$653K Sell
11,829
-419,407
-97% -$21.3M 0.01% 360
2016
Q2
$15.8M Sell
431,236
-20,250
-4% -$715K 0.21% 60
2016
Q1
$14.2M Buy
451,486
+277,311
+159% +$9.59M 0.18% 85
2015
Q4
$10.7M Buy
174,175
+29,880
+21% +$1.89M 0.06% 224
2015
Q3
$10M Buy
+144,295
New +$10M 0.07% 202

Other funds holding RDUS

ING Group's RDUS Position: Q3 2018 in Review

ING Group sold out of Radius Health, Inc. (RDUS) in Q3 2018, closing a stake of 221,753 shares — an estimated $6.54M sold.

ING Group first reported a position in RDUS in Q3 2015 and held it in 9 quarters. The position peaked at $15.8M in Q2 2016. 139 funds tracked by Wall St. Rank hold RDUS as of Q3 2018.

  • ING Group reported no remaining Radius Health, Inc. position as of Q3 2018 after selling out during the quarter.
  • ING Group sold 221,753 Radius Health, Inc. shares in Q3 2018, an estimated $6.54M.
  • ING Group first reported a position in Radius Health, Inc. in Q3 2015 and held it in 9 quarters.
  • ING Group's Radius Health, Inc. position peaked at $15.8M in Q2 2016.
  • 139 funds tracked by Wall St. Rank held Radius Health, Inc. as of Q3 2018.

Based on ING Group's 13F filing for Q3 2018, filed 6 Nov 2018.